Back
10X Genomics, Inc. 10K Form
Sell
37
TXG
10X Genomics, Inc.
Last Price:
$18.87
Seasonality Move:
-23.7%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TXG News And Ratings
See the #1 stock for the next 7 days that we like better than TXG
TXG Financial Statistics
Sales & Book Value
| Annual Sales: | $642.8M |
|---|---|
| Cash Flow: | $39M |
| Price / Cash Flow: | 18.13 |
| Annual Sales: | $6.24 |
| Price / Book: | 3.03 |
Profitability
| EPS (TTM): | -0.34960 |
|---|---|
| Net Income (TTM): | $-43.5M |
| Gross Margin: | $452.4M |
| Return on Equity: | -5.77% |
| Return on Assets: | -4.47% |
10X Genomics, Inc. Earnings Forecast
Key 10X Genomics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 9 years for TXG is 70.38%.
-
The Selling, General & Administrative Expenses for TXG have been equal to 49.18% of Gross Profit Margin.
-
The Research & Development expenses have been 37.12% of Revenue.
-
The Net Earning history of TXG is -6.77% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 4 years.
10X Genomics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | TXG |
| CUSIP: | 88025U |
| Website: | 10xgenomics.com |
Debt
| Debt-to-Equity Ratio: | 0.11 |
|---|---|
| Current Ratio: | 4.46 |
| Quick Ratio: | 3.72 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 115.59 |
TXG Technical Analysis vs Fundamental Analysis
Sell
37
10X Genomics, Inc. (TXG)
is a Sell
Is 10X Genomics, Inc. a Buy or a Sell?
-
10X Genomics, Inc. stock is rated a SellThe current 10X Genomics, Inc. [TXG] share price is $18.88. The Score for TXG is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.